EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieValidierungsstudie

Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate‐Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence

Laura Chamorro Castillo iD, Inés Rivero Belenchón, Ignacio Puche Sanz, Rocío Saiz Marenco, Ana Victoria Ojeda Claro, Néstor Sánchez Martínez, Rafael Medina López, Alvaro Juárez Soto, Jose Luis Álvarez Ossorio, Emilio García Galisteo, Julia Carrasco Valiente, Bernardo Herrera Imbroda und 7 weitere

The Prostate · 2025

DOI: 10.1002/pros.24910 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Prostate, 2025. Verfasst von Laura Chamorro Castillo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Urology Department, Reina Sofia University Hospital, IMIBIC, UCO, Córdoba, Spain. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Nomograms, Prostatic Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 23 Literaturangaben. Gefördert von: The study was supported by the Andalusia Association of Urology PSAMAND2023..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prostate‐specific membrane antigen (PSMA) PET/CT has been established as the standard imaging technique after biochemical recurrence (BCR) of prostate cancer (PCa). However, its availability is not widespread, thus, patient selection criteria are necessary. For this reason, a European nomogram was recently developed with the intention of helping to predict and identify those patients with BCR at high risk for a positive PSMA PET/CT. The aim of our study was to test the external validity of this nomogram in a large regional cohort of patients and its impact as a selective tool for patients with BCR who should undergo a PSMA PET/CT. Methodology A multicenter, observational, and retrospective study to validate, calibrate, and readjust the European PSMA PET/CT positivity prediction nomogram in a cohort of patients with BCR after radical treatments for localized PCa. Clinical and demographic data were analyzed. We evaluated the detection rate of PSMA PET/CT, the association of different variables with a positive PSMA PET/CT, and the accuracy of the nomogram, summarized in an ROC curve and a clinical decision curve. The nomogram was then modified and improved for our cohort.

Results

A cohort of 413 patients with BCR undergoing PSMA PET/CT was evaluated. Median age, PSA, and PSAdt were 66 years, 0.52 ng/mL, and 7 months, respectively. Median time to BCR was 34 months and the predominant ISUP was 3 (31%). Most patients underwent radical prostatectomy (88%). PSMA PET/CT was positive in 67% of patients, with pelvic involvement in 32% and 24% positivity outside the pelvis. The independent variables associated with a positive PSMA PET/CT were PSA value (OR: 1.94 (1.2–3.19), with a PSA level ≥ 0.5 ng/dL), and a PSA persistence after primary treatment (OR 2.95 (95% CI 1.37–7.14)). The original nomogram had a low predictive ability, with an AUC of 0.57 (95% CI: 0.52–0.62). It was necessary to adjust and calibrate this to obtain a novel nomogram with an AUC of 0.84 (95% CI 0.70–0.98). The DCA showed a greater net benefit from the use of this nomogram at intermediate threshold levels.

Conclusion

The nomogram showed a low predictive ability in our external validation. Nevertheless, our novel nomogram demonstrated a moderate‐high predictive ability, which could thus optimize the selection of BCR patients who are candidates for PSMA PET/CT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyNomogramsProstatic NeoplasmsNeoplasm Recurrence, LocalGlutamate Carboxypeptidase IIAntigens, SurfaceHumansMaleAgedRetrospective StudiesMiddle AgedProstate-Specific Antigen

Stichwörter der Autor:innen

PSMA PET/CTbiochemical recurrenceexternal validationnomogramprostate cancer

Substanzen

Glutamate Carboxypeptidase IIFOLH1 protein, humanAntigens, SurfaceProstate-Specific Antigen

Autor:innen und Institutionen

  • Urology Department, Reina Sofia University Hospital, IMIBIC, UCO, Córdoba, Spain.
  • Urology and Nephrology Department, Virgen del Rocío University Hospital, Biomedical Institute of Seville (IBiS)/Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain.
  • Urology Department, Hospital Universitario Virgen de las Nieves, Biosanitary Research ibs. GRANADA, Granada, Spain.
  • Urology Department, Jerez University Hospital, Jerez, Cádiz, Spain.
  • Urology Department, Puerta del Mar University Hospital, Cádiz, Cádiz, Spain.
  • Urology Department, Malaga Regional University Hospital, Málaga, Spain.

ORCID-Profile: Laura Chamorro Castillo, Enrique Gómez Gómez

Förderung

  • The study was supported by the Andalusia Association of Urology PSAMAND2023.

Zitieren

APA

Castillo, L. C., Belenchón, I. R., Sanz, I. P., Marenco, R. S., Ojeda Claro, A. V., Martínez, N. S., Medina López, R., Juárez Soto, A., Álvarez Ossorio, J. L., García Galisteo, E., Carrasco Valiente, J., Imbroda, B. H., Moreno Jiménez, J., Casas, J. A. V., Rodríguez, A., Ortiz, A. S., Hernández, J. P. C., Gómez Gómez, E., & PSMAAND Collaborators (2025). Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate‐Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence. The Prostate. https://doi.org/10.1002/pros.24910

Vancouver

Castillo LC, Belenchón IR, Sanz IP, Marenco RS, Ojeda Claro AV, Martínez NS, et al. Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate‐Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence. The Prostate. 2025. doi:10.1002/pros.24910

BibTeX
@article{Castillo2025,
  author = {Castillo, Laura Chamorro and Belenchón, Inés Rivero and Sanz, Ignacio Puche and Marenco, Rocío Saiz and Ojeda Claro, Ana Victoria and Martínez, Néstor Sánchez and Medina López, Rafael and Juárez Soto, Alvaro and Álvarez Ossorio, Jose Luis and García Galisteo, Emilio and Carrasco Valiente, Julia and Imbroda, Bernardo Herrera and Moreno Jiménez, Juan and Casas, Juan Antonio Vallejo and Rodríguez, Antonio and Ortiz, Adrián Santiago and Hernández, Juan Pablo Campos and Gómez Gómez, Enrique and PSMAAND Collaborators, PSMAAND Collaborators},
  title = {Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate‐Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence},
  journal = {The Prostate},
  year = {2025},
  doi = {10.1002/pros.24910}
}
Kostenlos starten →